Table 1 Rapid synthesized SeNPs antibacterial activity against clinical pathogens.
Pathogenic bacteria | Zone of inhibition in (mm) concentration of SeNPs (µg/mL) | ||||
|---|---|---|---|---|---|
25 µL | 50 µL | 75 µL | 100 µL | Control | |
Bacillus subtilis | 10 ± 0.81 | 14 ± 0.47 | 16 ± 1.24 | 17 ± 0.47 | 14 ± 0.81 |
Escherichia coli | 6 ± 0.81 | 10 ± 0.81 | 13 ± 0.94 | 15 ± 1.41 | 5 ± 0.81 |